Course curriculum

  • 1

    Cardiovascular

    • Abnormal ECG (September 2019)

    • ACE inhibitor and ARB use in diabetes (July 2018)

    • Acute Aortic dissection (January 2019)

    • Acute ischemic stroke - management - 4Qs (January 2019)

    • Amniotic fluid embolism (May 2019)

    • Anemia in children - 3Qs (May 2020)

    • Anemia in the elderly - 2Qs (March 2019)

    • Ankle brachial index testing (July 2019)

    • Anticoagulation and the surgical patient (January 2020)

    • Aortic dissection - 2Qs (May 2020)

    • Aspirin and primary prevention of cardiovascular disease - 2Qs (September 2019)

    • Atrial septal defects (November 2019)

    • Autoimmune hemolytic anemia (September 2018)

    • Behcet's syndrome - 3Qs (May 2020)

    • Beta-blockers - Perioperative (May 2020)

    • Beta-blockers and cardiovascular disease - 2Qs (November 2018)

    • Bicuspid aortic valve - 3Qs (July 2019)

    • Blood transfusion threshold (July 2018)

    • Blunt cardiac injury (May 2019)

    • Cardiogenic shock - 2Qs (July 2018)

    • Cardiomyopathy - Hypertrophic- 3Qs (January 2020)

    • Carotid stenosis (November 2019)

    • Central retinal artery occlusion (July 2019)

    • Chronic hypertension and pregnancy - 3Qs (March 2020)

    • Contraception and cardiovascular disease - 2Qs (May 2019)

    • Coronary artery calcium screening (January 2020)

    • Cyanotic heart disease - 4Qs (March 2020)

    • DASH eating plan (September 2018)

    • Digoxin toxicity (November 2018)

    • Drowning (September 2019)

    • Deep venous thrombosis and long distance travel (November 2019)

    • Dietary salt and cardiovascular disease - 2Qs (May 2019)

    • Eosinophilia - 2Qs (May 2020)

    • Erectile dysfunction and lifestyle modification - 2Qs (September 2019)

    • Evaluation of the patient with bleeding - 4Qs (January 2019)

    • Headache in pregnancy - 3Qs (July 2019)

    • HIV and cardiovascular disease -2Qs (January 2020)

    • Hodgkin lymphoma - Classic - 5Qs (May 2020)

    • Hydroxyurea and sickle cell disease - 2Qs (January 2019)

    • Hyperlipidemia - nonstatin treatment (September 2020)

    • Hypertension - Gestational - 3Qs (March 2020)

    • Hypertriglyceridemia - 2Qs (November 2018)

    • Intracranial aneurysm (July 2018)

    • Intracranial arterial stenosis (September 2018)

    • Ischemic stroke - management - 4Qs (November 2018)

    • Kawasaki disease (May 2019)

    • Lipid guidelines - 3Qs (May 2019)

    • Macrocytic anemia - 5Qs (July 2019)

    • Mechanical heart valve and pregnancy - 2Qs (May 2019)

    • Mitral valve prolapse - 2Qs (May 2019)

    • NSAIDs and cardiovascular disease - 2Qs (January 2019)

    • Oral contraceptives and risk of venous thromboembolism (March 2020)

    • Patent foramen ovale - 2Qs (March 2020)

    • Pericarditis - Acute - 2Qs (September 2018)

    • Postpartum eclampsia (January 2019)

    • Postprandial hypotension - 2Qs (May 2020)

    • Postural orthostatic tachycardia syndrome (September 2019)

    • Pulmonary embolism - incidental (January 2019)

    • Pulmonary embolism - subsegmental - 2Qs (March 2019)

    • Resistant hypertension - 2Qs (September 2018)

    • Sports and co-morbid conditions - 3Qs (January 2020)

    • Statins and primary prevention - 2Qs (July 2019)

    • Superficial thrombophlebitis (January 2020)

    • Systolic Blood Pressure Intervention Trial (SPRINT) (November 2018)

    • Systolic hypertension - Isolated - 2Qs (May 2020)

    • Takotsubo cardiomyopathy - 3Qs (January 2020)

    • Temporal arteritis (March 2019)

    • Thrombocytosis (November 2018)

    • Thrombolysis after stroke -2Qs (March 2020)

    • Thrombotic thrombocytopenic purpura - 2Qs (September 2019)

    • Transfusion reactions - 3Qs (March 2019)

    • Understanding lipid recommendations - 2Qs (September 2018)

    • Unprovoked venous thrombosis - 4Qs (November 2019)

    • Venous thromboembolism and malignancy - 2Qs (January 2019)